Equities

Smith & Nephew PLC

SN.:LSE

Smith & Nephew PLC

Health CareMedical Equipment and Services
  • Price (GBX)1,267.00
  • Today's Change-26.50 / -2.05%
  • Shares traded2.15m
  • 1 Year change23.61%
  • Beta1.0606
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Smith & Nephew PLC grew revenues 4.70% from 5.55bn to 5.81bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 56.65% net income growth from 263.00m to 412.00m.
Gross margin70.04%
Net profit margin8.26%
Operating margin12.75%
Return on assets4.62%
Return on equity9.14%
Return on investment5.48%
More ▼

Cash flow in USDView more

In 2024, Smith & Nephew PLC increased its cash reserves by 105.67%, or 317.00m. The company earned 987.00m from its operations for a Cash Flow Margin of 16.99%. In addition the company used 569.00m on investing activities and also paid 86.00m in financing cash flows.
Cash flow per share0.9494
Price/Cash flow per share12.82
Book value per share4.64
Tangible book value per share1.23
More ▼

Balance sheet in USDView more

Smith & Nephew PLC has a Debt to Total Capital ratio of 38.42%, a lower figure than the previous year's 62.92%.
Current ratio3.00
Quick ratio1.40
Total debt/total equity0.6239
Total debt/total capital0.3842
More ▼

Growth rates in USD

Year on year, growth in dividends per share fell -7.54% while earnings per share excluding extraordinary items rose 56.12%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.44%
Div growth rate (5 year)-2.01%
Payout ratio (TTM)41.14%
EPS growth(5 years)-7.22
EPS (TTM) vs
TTM 1 year ago		59.88
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.